Arkolith/Insider Trading/MNPR/Form 4

Vu Quan Anh

Chief Financial OfficerMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Dec 29, 2025
Net Buying
Open-Market Buys
$105K
Open-Market Sells
$0
Net Open-Market Flow
$105K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 26, 2025Buy(P)2K$69.95$105K2K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-038804) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML